Clinical Trials Browser

Unknown × Tyrosine Kinase Inhibitors × Other hematologic neoplasm × Clear all

NCT06121765 2023-11-08

Metabolic Alternation and Clinicohematological Characteristic in Chronic Phase CML in Patient Treated With TKI

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT02687425 2016-02-22

SESPI

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive